Krishnendu ChakrabortyKrish was awarded Ph.D. in Life Sciences from Jadavpur University, Kolkata, India in 2010. During his doctoral research he studied cancer mediated Immunosuppression and role of Neem leaf glycoprotein (NLGP) and Interferon alpha 2b as an immune modulator in the maintenance of immune homeostasis during head and neck squamous cell carcinoma (HNSCC). After finishing his doctoral thesis I joined Dept. of Pathobiological Sciences, Louisiana State University, USA and pursued his further research in the field of viral immunology. As a postdoctoral researcher he studied the role of immune modulatory cytokines in human metapneumo virus (hMPV) infection model. Presently he is working as a postdoctoral scientist in the Dept. of Lymphocyte Signalling Lab and Development, Babraham Institute, Cambridge, UK. His current interest is to determine the role of Phosphokinases and RNA binding proteins in Influenza virus infection.
Abdelrasoul H, Werner M, Setz CS
8 2045-2322:1327 (2018)
Kishore M, Cheung KCP, Fu H
47 1097-4180:875-889.e10 (2017)
Stubbs TM, Bonder MJ, Stark AK
18 1474-760X:68 (2017)
Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4(+) T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals.
Mauro C, Smith J, Cucchi D
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy.
Okkenhaug K, Graupera M, Vanhaesebroeck B
Eil R, Vodnala SK, Clever D
537 1476-4687:539-543 (2016)
Lucas CL, Chandra A, Nejentsev S
Nature reviews. Immunology
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.
Coulter TI, Chandra A, Bacon CM
The Journal of allergy and clinical immunology
Roychoudhuri R, Clever D, Li P
Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
Barbera Betancourt A, Emery JL, Recino A
11 1932-6203:e0146516 (2016)
PI3Kδ promotes CD4(+) T cell interactions with antigen presenting cells by increasing LFA-1 binding to ICAM-1.
Garçon F, Okkenhaug K
Immunology and cell biology
Roychoudhuri R, Eil RL, Clever D
The Journal of clinical investigation